Cetera Trust Company’s Idexx Laboratories IDXX Stock Holding History

Cetera Trust Company’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18	Closed	-$9.99K	–	418
2023 Q4	$9.99K	Buy	+18	New	+$8.45K	0.01%	292

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cetera Trust Company's IDXX Position: Q1 2024 in Review

Cetera Trust Company sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 18 shares — an estimated $9.99K sold.

Cetera Trust Company first reported a position in IDXX in Q4 2023 and held it in 1 quarter. The position peaked at $9.99K in Q4 2023. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Cetera Trust Company reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Cetera Trust Company sold 18 Idexx Laboratories shares in Q1 2024, an estimated $9.99K.
Cetera Trust Company first reported a position in Idexx Laboratories in Q4 2023 and held it in 1 quarter.
Cetera Trust Company's Idexx Laboratories position peaked at $9.99K in Q4 2023.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Cetera Trust Company's 13F filing for Q1 2024, filed 8 May 2024.